Cerenome announces new dual mechanism of action for lead drug REYOBIQ

Cerenome announced a new dual mechanism of action for its lead investigational drug REYOBIQ, featuring lethal DNA damage and beneficial immunomodulation.

Detected & updated continuously · Source: Nebula